Allergan

$183.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.14 (+0.62%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Allergan and other stocks, options, ETFs, and crypto commission-free!

About AGN

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. Read More The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

Employees
16,900
Headquarters
Dublin, Dublin
Founded
1984
Market Cap
60.27B
Price-Earnings Ratio
Dividend Yield
2.15
Average Volume
2.74M
High Today
$183.77
Low Today
$182.39
Open Price
$182.80
Volume
2.49M
52 Week High
$183.79
52 Week Low
$114.27

Collections

AGN News

BenzingaNov 14

Allergan, Exicure Strike Collaboration Agreement For Hair Loss Disorder Drugs

Shares of the thinly traded micro-cap Exicure Inc (NASDAQ: XCUR) were advancing strongly Thursday in the wake of a collaboration agreement announced by the comp
78
MarketWatchNov 14

Exicures shares up on Allergan partnership

Shares of Exicure XCUR, -4.65% are up 26% in premarket trading on the news that the biotechnology company entered into an agreement with Allergan AGN, -0.20% to
6
MarketWatchNov 13

AbbVie sells $30 billion in bonds to help fund Allergan acquisition

AbbVie Inc. ABBV, +0.25% sold $30 billion of bonds Tuesday to help fund its acquisition of Allergan AGN, -0.20% PLC, taking advantage of investors’ strong deman
99

AGN Earnings

$3.36
$3.71
$4.07
$4.42
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
$4.22 per share
Actual
$4.25 per share

You May Also Like

More AGN News

BloombergNov 12

AbbVie Kicks Off Mega Bond Sale to Finance Allergan Acquisition

(Bloomberg) -- AbbVie Inc. is selling bonds to help finance its $63 billion acquisition of Allergan Plc, in what will likely be the largest bond sale this year.
1,084
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.